References
- KesslerRCAguilar-GaxiolaSAlonsoJThe global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveysEpidemiol Psichiatr Soc20091812333 Italian19378696
- LepineJPGasquetIKovessVPrevalence and comorbidity of psychiatric disorders in the French general populationL’Encephale2005312182194 French15959445
- AlonsoJAngermeyerMCBernertS12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatr Scand20044202837
- KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
- HendersonSAndrewsGHallWAustralia’s mental health: an overview of the general population surveyAust N Z J Psychiatry200034219720510789524
- RegierDANarrowWEKuhlEAKupferDJThe conceptual development of DSM-VAm J Psychiatry2009166664565019487400
- World Health OrganizationThe Global Burden of Disease: 2004 UpdateGeneva, SwitzerlandWorld Health Organization2004
- OrmelJPetukhovaMChatterjiSDisability and treatment of specific mental and physical disorders across the worldBr J Psychiatry2008192536837518450663
- EspositoEWangJLWilliamsJVPattenSBMood and anxiety disorders, the association with presenteeism in employed members of a general population sampleEpidemiol Psichiatr Soc2007163231237 Italian18020197
- LepineJPEpidemiology, burden, and disability in depression and anxietyJ Clin Psychiatry200162Suppl 1341011434418
- AlonsoJAngermeyerMCBernertSDisability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatr Scand Suppl2004420384615128386
- PapakostasGIPetersenTMahalYMischoulonDNierenbergAAFavaMQuality of life assessments in major depressive disorder: a review of the literatureGen Hosp Psychiatry2004261131714757297
- SheehanKHSheehanDVAssessing treatment effects in clinical trials with the discan metric of the Sheehan Disability ScaleInt Clin Psychopharmacol2008232708318301121
- National Institute of Mental HealthCGI, Clinical Global ImpressionGuyWECDEU Assessment Manual of Psychopharmacology ReviewRockville, MDNational Institute of Mental Health1976
- SheehanDVHarnett-SheehanKRajBAThe measurement of disabilityInt Clin Psychopharmacol199611Suppl 389958923116
- ZigmondASSnaithRPThe Hospital Anxiety and Depression ScaleActa Psychiatr Scand19836763613706880820
- RushAJBoseAEscitalopram in clinical practice: results of an open-label trial in a naturalistic settingDepress Anxiety2005211263215786487
- StamouliSSYfantisALamboussisEEscitalopram in clinical practice in Greece: treatment response and tolerability in depressed patientsExpert Opin Pharmacother200910693794519364246
- BandelowBZoharJHollanderEWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revisionWorld J Biol Psychiatry20089424831218949648
- BauerMBschorTPfennigAWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary careWorld J Biol Psychiatry2007826710417455102
- SteinDJBandelowBDolbergOTAndersenHFBaldwinDSAnxiety symptom severity and functional recovery or relapseAnn Clin Psychiatry2009212818819439157
- BandelowBBaldwinDSDolbergOTAndersenHFSteinDJWhat is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?J Clin Psychiatry20066791428143417017830
- LepineJPGastparMMendlewiczJTyleeADepression in the community: the first pan-European study DEPRES (Depression Research in European Society)Int Clin Psychopharmacol199712119299179630
- MartinezLGasquetILenneXSSRI antidepressant prescription: compliance with recommendations?Rev Prat Med Gen20031762310931098 French